Advanced MRI Biomarkers and Deep Learning for Efficient Clinical Trials in Frontotemporal Dementia Subtypes

This study highlights the utility of advanced imaging biomarkers in differentiating FTD subtypes and monitoring progression. The integration of volumetric and dMRI metrics, along with deep learning segmentation, offers precise, early detection of changes, thereby reducing sample size requirements and enabling cost-effective, efficient clinical trials. Furthermore, this approach offers insights into the unique spatial and temporal progression patterns of each FTD subtype, paving the way for personalized intervention strategies.